2026

Regulatory Approvals

FDA Approves Atezolizumab in Combination With Chemotherapy for Stage III dMMR Colon Cancer

Oct 9, 2026

FDA Approves Atezolizumab in Combination With Chemotherapy for Stage III dMMR Colon Cancer The ASCO Post

Regulatory Approvals

FDA Approves Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer

Oct 9, 2026

FDA Approves Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer Oncology News Central

Regulatory Approvals

Teva wins FDA approval for monthly schizophrenia injection Weltruza

Oct 9, 2026

Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters

Credit Ratings

Fitch upgrades Hannover Re’s outlook to positive, maintaining ‘AA-’ rating

Oct 9, 2026

Fitch upgrades Hannover Re’s outlook to positive, maintaining ‘AA-’ rating Reinsurance News

Credit Ratings

S&P Global Ratings Assigns Corporation for Supportive Housing ‘A+’ Issuer Credit Rating with Stable Outlook – Laurel Leader

Oct 9, 2026

S&P Global Ratings Assigns Corporation for Supportive Housing 'A+' Issuer Credit Rating with Stable Outlook Laurel Leader-Call

Mergers & Acquisitions

Driven by A.I. Boom, Marvell and Lumentum Announce $115 Billion Merger

Labor

Split NLRB Backs Union Election Order At Chemical Co.

Labor

Nearly 90 Wells Fargo employees in Roanoke facing layoffs

Labor

Why some CSU faculty are ready for a strike: ‘The last contract sucked’